Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Translarna 250 mg granules for oral suspension {equilateral_black_triangle}

Active Ingredient:
ataluren
Company:  
PTC Therapeutics Ltd See contact details
ATC code: 
M09AX03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 22 Jul 2021

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
PTC Therapeutics Ltd
Company image
Address
Building 2, Ground Floor, Guildford Business Park, Guildford, GU2 8XG, UK
WWW
http://www.ptcbio.co.uk
Telephone
+44 (0)1483 246 865
Medical Information Direct Line
0345 075 4864
Medical Information e-mail
[email protected]